Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Victor Ambros, Gary Ruvkun, Robert Bitterman, Keith Brownlie

Premium

University of Massachusetts Medical School researcher Victor Ambros and Massachusetts General Hospital investigator Gary Ruvkun have received the 2012 Dr. Paul Janssen Award for Biomedical Research for their co-discovery of microRNAs.

Ambros' lab discovered the first miRNA, while Ruvkun's lab independently identified how these small, non-coding RNAs regulate their target mRNA, according to Johnson & Johnson, which sponsors the award.

“Working together, they demonstrated that the miRNA inactivates its target through direct, base-pairing interactions,” the company said.


RXi Pharmaceuticals has appointed Robert Bitterman and Keith Brownlie to its board of directors.

Bitterman is currently the president and CEO of Cutanea Life Sciences, and Brownlie previously worked as metro New York area life sciences industry leader for Ernst & Young.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.